Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nanjing Leads Biolabs Co.,ltd

Clinical trials sponsored by Nanjing Leads Biolabs Co.,ltd, explained in plain language.

Nanjing Leads Biolabs 9887 HKEX

Nanjing Leads Biolabs is a biopharmaceutical company focused on developing innovative antibody drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 11 Not yet recruiting 1 Completed 4

Can a new drug boost chemotherapy for a rare cancer?

Disease control Not yet recruiting

This phase III trial is testing whether adding an experimental drug called LBL-024 to standard chemotherapy can help people with advanced extrapulmonary neuroendocrine carcinoma (EP-NEC), a rare and aggressive cancer. Participants will receive either LBL-024 or a placebo alongsid…

Phase: PHASE3 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC